DOI: 10.1055/s-00000025

Hormone and Metabolic Research

Issue 11/12 · Volume 36 · November/December 2004 DOI: 10.1055/s-002-3846

Editorial

  • 733
    Ahrén , B.; Gromada , J.; Schmitz , O.:

    Incretin Hormones and Insulin Secretion

    • Review

  • 735
    Rehfeld, J. F.:

    A Centenary of Gastrointestinal Endocrinology

  • 742
    Efendic, S.; Portwood, N.:

    Overview of Incretin Hormones

  • 747
    Holst, J. J.:

    On the Physiology of GIP and GLP-1

  • 755
    Dubé , P. E.; Brubaker , P. L.:

    Nutrient, Neural and Endocrine Control of Glucagon-like Peptide Secretion

  • 761
    Deacon, C. F.:

    Circulation and Degradation of GIP and GLP-1

  • 766
    Thorens, B.:

    Physiology of GLP-1 - Lessons from Glucoincretin Receptor Knockout Mice

  • 771
    Yamada , Y.; Seino , Y.:

    Physiology of GIP - A Lesson from GIP Receptor Knockout Mice

  • 775
    Del Prato, S.; Marchetti, P.:

    Beta- and Alpha-Cell Dysfunction in Type 2 Diabetes

  • 782
    Wideman, R. D.; Kieffer, T. J.:

    Glucose-dependent Insulinotropic Polypeptide as a Regulator of Beta Cell Function and Fate

  • 804
    Perfetti, R.; Hui, H.:

    The Role of GLP-1 in the Life and Death of Pancreatic Beta Cells

  • 811
    Stoffers, D. A.:

    The Development of Beta-cell Mass: Recent Progress and Potential Role of GLP-1

  • 822
    Gromada , J.; Rorsman , P.:

    New Insights into the Regulation of Glucagon Secretion by Glucagon-like Peptide-1

  • 830
    Vella, A.; Rizza, R. A.:

    Extrapancreatic Effects of GIP and GLP-1

  • 837
    D'Alessio, D.; Vahl, T.; Prigeon, R.:

    Effects of Glucagon-like Peptide 1 on the Hepatic Glucose Metabolism

  • 842
    Ahrén, B.:

    GLP-1 and Extra-islet Effects

  • 846
    Dhillo, W. S.; Bloom, S. R.:

    Gastrointestinal Hormones and Regulation of Food Intake

  • 852
    Nauck, M. A.:

    Glucagon-like Peptide 1 (GLP-1) in the Treatment of Diabetes

  • 859
    Meier, J. J.; Nauck, M. A.:

    GIP as a Potential Therapeutic Agent?

  • 867
    Ahrén, B.; Schmitz, O.:

    GLP-1 Receptor Agonists and DPP-4 Inhibitors in the Treatment of Type 2 Diabetes

    • Original

  • 787
    Holz, G.:

    New Insights Concerning the Glucose-dependent Insulin Secretagogue Action of Glucagon-like Peptide-1 in Pancreatic β-Cells

  • 795
    Sörhede Winzell, M.; Ahrén, B.:

    Glucagon-like Peptide-1 and Islet Lipolysis